Technical Analysis for VYGR - Voyager Therapeutics, Inc.

Grade Last Price % Change Price Change
C 9.09 -2.05% -0.19
VYGR closed down 2.05 percent on Monday, March 18, 2024, on approximately normal volume.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Pocket Pivot Bullish Swing Setup -2.05%
Volume Surge Other -2.05%
Wide Bands Range Expansion -2.05%
NR7 Range Contraction -0.44%
Narrow Range Bar Range Contraction -0.44%
Inside Day Range Contraction -0.44%
Wide Bands Range Expansion -0.44%
Wide Bands Range Expansion -0.55%
Gapped Down Weakness -0.55%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 15 hours ago
60 Minute Opening Range Breakout about 18 hours ago
10 DMA Support about 19 hours ago
Down 1% about 19 hours ago
Fell Below 10 DMA about 19 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Voyager Therapeutics, Inc. Description

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe diseases of the central nervous system (CNS). The company focuses in the field of adeno-associated virus gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease; and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich's ataxia, and VY-HTT01 for Huntington's disease, as well as VY-SMN101 for neuromuscular disease. The company has strategic collaborations with Genzyme Corporation and the University of Massachusetts Medical School. Voyager Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Gene Therapy Genetics Parkinson's Disease Amyotrophic Lateral Sclerosis Treatment Of Parkinson's Disease Huntington's Disease Genzyme Monogenic Ataxia Friedreich's Ataxia Neuromuscular Disease Severe Diseases

Is VYGR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.3398
52 Week Low 6.06
Average Volume 738,162
200-Day Moving Average 8.65
50-Day Moving Average 8.15
20-Day Moving Average 8.85
10-Day Moving Average 9.19
Average True Range 0.52
RSI (14) 56.90
ADX 37.55
+DI 28.33
-DI 10.80
Chandelier Exit (Long, 3 ATRs) 9.08
Chandelier Exit (Short, 3 ATRs) 8.86
Upper Bollinger Bands 10.07
Lower Bollinger Band 7.62
Percent B (%b) 0.6
BandWidth 27.68
MACD Line 0.34
MACD Signal Line 0.36
MACD Histogram -0.0184
Fundamentals Value
Market Cap 505.32 Million
Num Shares 55.6 Million
EPS 1.16
Price-to-Earnings (P/E) Ratio 7.84
Price-to-Sales 2.71
Price-to-Book 2.40
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.51
Resistance 3 (R3) 9.55 9.46 9.44
Resistance 2 (R2) 9.46 9.35 9.44 9.42
Resistance 1 (R1) 9.27 9.28 9.23 9.23 9.39
Pivot Point 9.18 9.18 9.15 9.16 9.18
Support 1 (S1) 8.99 9.07 8.95 8.95 8.79
Support 2 (S2) 8.90 9.00 8.88 8.76
Support 3 (S3) 8.71 8.90 8.74
Support 4 (S4) 8.67